Atticus Wealth Management’s Cardinal Health CAH Stock Holding History

Atticus Wealth Management’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-6	Closed	–	–	325
2019 Q4	$0	Buy	+6	New	+$310	﹤0.01%	386

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Atticus Wealth Management's CAH Position: Q1 2020 in Review

Atticus Wealth Management sold out of Cardinal Health (CAH) in Q1 2020, closing a stake of 6 shares.

Atticus Wealth Management first reported a position in CAH in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 721 funds tracked by Wall St. Rank hold CAH as of Q1 2020.

Atticus Wealth Management reported no remaining Cardinal Health position as of Q1 2020 after selling out during the quarter.
Atticus Wealth Management sold 6 Cardinal Health shares in Q1 2020.
Atticus Wealth Management first reported a position in Cardinal Health in Q4 2019 and held it in 1 quarter.
Atticus Wealth Management's Cardinal Health position peaked at $0 in Q4 2019.
721 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2020.

Based on Atticus Wealth Management's 13F filing for Q1 2020, filed 23 Apr 2020.